A year of HRT ups breast cancer risk
Excess risk increased steadily with duration of use, say researchers
Menopausal women prescribed hormone therapy for more than a year have a greater risk of breast cancer compared with those who have never used the treatment, a landmark study has found.
The elevated risk persists even after ceasing HRT and for up to 15 years post-therapy, the UK researchers say.
